These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25168823)

  • 21. Extranodal Ocular Adnexal Marginal Zone Lymphoma in a Ten-Year-Old Child.
    Çetingül N; Palamar M; Hacıkara Ş; Kamer S; Hekimci Özdemir H; Ataseven E; Barut Selver Ö; Hekimgil M
    Turk J Ophthalmol; 2020 Mar; 50(1):53-55. PubMed ID: 32167265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjunctival MALT lymphoma: utility of FDG PET/CT for diagnosis, staging, and evaluation of treatment response.
    Sallak A; Besson FL; Pomoni A; Christinat A; Adler M; Aegerter JP; Nguyen C; de Leval L; Frossard V; Prior JO
    Clin Nucl Med; 2014 Mar; 39(3):295-7. PubMed ID: 24458180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
    Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
    Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous regression of bilateral conjunctival extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
    Matsuo T; Ichimura K; Yoshino T
    J Clin Exp Hematop; 2007 Nov; 47(2):79-81. PubMed ID: 18040147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-Hodgkin lymphoma of the conjunctiva (MALT lymphoma)--clinical and pathological markers].
    Meyer P; Gudat F
    Klin Monbl Augenheilkd; 1998 May; 212(5):407-9. PubMed ID: 9677594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favourable response to rituximab by an ocular adnexal primary lymphoma.
    Luque Valentin-Fernandez ML; Alvarez Rodríguez F; Rodríguez Jiménez I
    Arch Soc Esp Oftalmol; 2016 Nov; 91(11):539-542. PubMed ID: 27125186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary MALT lymphoma of orbit:a clinicopathological study of 77 cases].
    Bi YW; Chen RJ; Hou YY; Li XP
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):414-5. PubMed ID: 17822630
    [No Abstract]   [Full Text] [Related]  

  • 28. Conjunctival lymphoma can be detected by FDG PET.
    Matsuo T; Ichimura K; Tanaka T; Kaji M
    Clin Nucl Med; 2012 May; 37(5):516-9. PubMed ID: 22475910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local recurrence as immunoglobulin G4 (IgG4)-related disease 10 years after radiotherapy to ocular adnexal extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
    Matsuo T; Ichimura K; Yoshino T
    J Clin Exp Hematop; 2011; 51(2):125-33. PubMed ID: 22104312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit.
    Izambart C; Robert PY; Petellat F; Petit B; Gastaud P; Lagier J; Labrousse F; Adenis JP
    Orbit; 2008; 27(5):345-9. PubMed ID: 18836931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous regression of a large-cell lymphoma in the conjunctiva and orbit.
    Chang YC; Chang CH; Liu YT; Tsai KB; Liu TC; Lin YN
    Ophthalmic Plast Reconstr Surg; 2004 Nov; 20(6):461-3. PubMed ID: 15599248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular adnexal lymphoma: assessment of a tumor-node-metastasis staging system.
    Aronow ME; Portell CA; Rybicki LA; Sweetenham JW; Singh AD
    Ophthalmology; 2013 Sep; 120(9):1915-9. PubMed ID: 23664470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A lymphoid conjunctival tumor--clinical aspects; therapeutical options.
    Apostol S; Filip M; Nechita A; Filip A
    Oftalmologia; 2005; 49(1):26-9. PubMed ID: 15934333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
    Yoo SB; Kim YA; Jeon YK; Kim CW
    Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
    Coupland SE
    Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular/adnexal lymphoma: dissimilar to systemic lymphoma.
    Rubinstein TJ; Aziz HA; Bellerive C; Sires BS; Hing AW; Habermehl G; Hsi E; Singh AD
    Surv Ophthalmol; 2018; 63(3):381-388. PubMed ID: 28837797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjunctival lymphoma in right eye: Case report.
    Parada-Vásquez RH; Lomas-Guaman VE; León-Roldán CR
    Arch Soc Esp Oftalmol; 2017 Feb; 92(2):78-81. PubMed ID: 27388111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clarithromycin therapy of a B cell MALT lymphoma].
    Danilko L; Haas K; Schönherr U; Tschurtschenthaler G
    Ophthalmologe; 2013 May; 110(5):447-50. PubMed ID: 23224128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory follicular conjunctival lesions: overlook as just inflammation or not?
    Jung SK; Paik JS; Park GS; Cho SG; Yang SW
    Br J Ophthalmol; 2019 Nov; 103(11):1660-1665. PubMed ID: 30709807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical conjunctival CD5 positive mucosa-associated lymphoid tissue (MALT) lymphoma.
    Agarwal PK; Lim LT; Fern A
    Semin Ophthalmol; 2012; 27(3-4):46-7. PubMed ID: 22784262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.